APOA1 and atherosclerosis: In addition, BBR also inhibits the formation of foam cells, regulates lipid metabolism, and inhibits atherosclerosis related inflammatory reactions by regulating the levels of visfatin, oxLDL, PON1, APOA1, GPD2, ABCG1, and AMPK, which may have good clinical value for the treatment of cardiovascular diseases.